Hyperphosphataemia after Phenylpropanolamine (Proin) in dogs
53 reports to the FDA describe hyperphosphataemia in dogs given Phenylpropanolamine. That is 1.3% of all reports for this medicine, compared with 0.6% across reports for all dog medicines, so it is reported unusually often with this medicine.
53Reports
81%Marked serious
9.4%Recovered
36%Died or euthanised
40 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Phenylpropanolamine treats urinary incontinence.
Products with this ingredient include Proin. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Phenylpropanolamine cause hyperphosphataemia in dogs?
- 53 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 40 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Hyperphosphataemia with similar medicines
- Hyperphosphataemia after Trilostane (Vetoryl) 373 reports · 3.1% of its reports
- Hyperphosphataemia after Insulin 48 reports · 0.7% of its reports
- Hyperphosphataemia after Levothyroxine 41 reports · 1.4% of its reports
All reported side effects of Phenylpropanolamine in dogs · Medicines most reported with hyperphosphataemia